)
Edge17 Apr 2026
The New York Times Company: Adapting to the Times
How The New York Times Company built on a century-long legacy of trusted journalism to navigate disruption and reshape its business model.
Q32 Bio
Q32 Bio (QTTB) investor relations material
Q32 Bio 25th Annual Needham Virtual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.25th Annual Needham Virtual Healthcare Conference summary15 Apr, 2026
Company overview and pipeline
Focuses on immune and inflammatory diseases, aiming to rebalance the immune system with lead asset bempikibart in phase II for alopecia areata, with mid-year data expected.
Additional research programs are ongoing, with future updates anticipated.
Mechanism of action and therapeutic rationale
Bempikibart is a bifunctional antibody targeting IL-7 and TSLP receptor alpha, modulating both autoimmune and allergic pathways.
Demonstrates full receptor occupancy in studies, potentially enabling broad disease coverage.
Alopecia areata landscape and unmet needs
Current AA treatments are limited, especially for moderate to severe cases; JAK inhibitors have black box warnings and require frequent monitoring.
Substantial unmet need exists for safer, effective alternatives; bempikibart aims to fill this gap.
Impact of 36-week dosing on Part B efficacy
Safety advantages over JAK inhibitors in AA
ADX-097 milestones and cash runway through 2027
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Q32 Bio
- Bempikibart delivers durable, safe hair regrowth in AA, with pivotal data expected mid-2026.QTTB
Company presentation10 Mar 2026 - Q4 2025 net income surged on asset sales, with cash runway secured into late 2027.QTTBQ4 202510 Mar 2026
- Bempikibart shows promise as a safer, durable biologic for alopecia areata, with key data due midyear.QTTBOppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026
- Durable hair regrowth in AA positions bempikibart as a potential first-line biologic therapy.QTTBTD Cowen 45th Annual Healthcare Conference3 Feb 2026
- Phase II readouts for benpicobart in atopic dermatitis and alopecia are expected in Q4 2024.QTTB2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Phase II data for novel therapies in atopic dermatitis and alopecia areata expected Q4 2024.QTTBStifel 2024 Immunology and Inflammation Virtual Summit20 Jan 2026
- Phase 2a data for bempikibart in AD and AA expected December; complement 097 data next year.QTTBGuggenheim’s Inaugural Healthcare Innovation Conference14 Jan 2026
- Bempikibart delivers durable hair regrowth in AA, with phase III preparations underway.QTTBLeerink Global Healthcare Conference 202526 Dec 2025
- Durable, remissive hair regrowth in severe alopecia areata positions bempikibart as a potential first-in-class biologic.QTTBOppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 202524 Dec 2025
Next Q32 Bio earnings date
Q1 202614 May, 2026
Q32 Bio
Next Q32 Bio earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage